Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Status:	Active, not recruiting
Conditions:	Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	9/13/2018
Start Date:	June 2013
End Date:	June 2019

The purpose of this study is to better understand how effective ablation is for destroying
tumor cells in the kidney and whether quality of life is improved for patients. Participation
in ARMOR may involve retrospective data collection only, combined retrospective and
prospective data collection, or prospective data collection

Inclusion Criteria:

Retrospective enrollment:

- Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal
mass.

Prospective enrollment:

- Patients scheduled to undergo, rather than having undergone, percutaneous, open or
laparoscopic energy ablation of a renal mass.

Exclusion Criteria:

- Patients not having undergone, or considered candidates for percutaneous, open or
laparoscopic energy ablation of a renal mass

- Non-English speaking patients

- Patients under the age of 18.

We found this trial at

sites

University of Maryland Medical Center

22 S Greene St
Baltimore, Maryland 21201

(410) 328-8667